Author:
Randall Thomas C.,Armstrong Katrina
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Oncology
Reference44 articles.
1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5–29.
2. Kim S, Dolecek TA, Davis FG. Racial differences in stage at diagnosis and survival from epithelial ovarian cancer: a fundamental cause of disease approach. Soc Sci Med. 2010;71(2):274–81.
3. Narod SA, Boyd J. Current understanding of the epidemiology and clinical implications of BRCA1 and BRCA2 mutations for ovarian cancer. Curr Opin Obstet Gynecol. 2002;14(1):19–26.
4. Norquist, B.M., et al., Inherited Mutations in Women With Ovarian Carcinoma. JAMA Oncol, 2015: p. 1–9. Using next generation sequencing techniques the authors demonstrate that close to 20% of ovarian cancer is associated with a germline mutation in a cancer susceptibility gene. The majority of these are in BRCA1/2.
5. Chen S, Parmigiani G. Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol. 2007;25(11):1329–33.
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献